Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Study suggests increased durability of immune responses towards SARS-CoV-2 spike protein after BNT62b2 booster

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Potent pan-β-CoV human monoclonal antibody has in vivo activity in multiple animal models

Study shows SARS-CoV-2 infection induces global alterations of the host endomembrane system

Study shows SARS-CoV-2 infection induces global alterations of the host endomembrane system

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Further optimization of cysteine-reactive pyrazoline-based covalent inhibitors for the SARS-CoV-2 Mpro

Further optimization of cysteine-reactive pyrazoline-based covalent inhibitors for the SARS-CoV-2 Mpro

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Study shows competitive fitness of emerging SARS-CoV-2 variants linked to their distinctiveness relative to identified lineages

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

Individual-based model describing the transmission and spread of SARS-CoV-2 in the Belgian population

Individual-based model describing the transmission and spread of SARS-CoV-2 in the Belgian population

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Quantification of hydrophobic interactions encoded by FP1 sequences of SARS-CoV-2 and MERS-CoV by single-molecule force measurements

Quantification of hydrophobic interactions encoded by FP1 sequences of SARS-CoV-2 and MERS-CoV by single-molecule force measurements

How does COVID-19 affect arrythmia?

How does COVID-19 affect arrythmia?

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Association of benzodiazepines with SARS-CoV-2 positivity and clinical outcomes in three patient groups

Association of benzodiazepines with SARS-CoV-2 positivity and clinical outcomes in three patient groups

The trajectory of B-cell immunity six months after mRNA vaccination

The trajectory of B-cell immunity six months after mRNA vaccination

Long COVID symptoms in families a year after SARS-CoV-2 infection or household exposure

Long COVID symptoms in families a year after SARS-CoV-2 infection or household exposure

Causal links between severe COVID-19 and blood proteins identified via proteome-wide Mendelian randomization in new study

Causal links between severe COVID-19 and blood proteins identified via proteome-wide Mendelian randomization in new study

Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.